SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-010227
Filing Date
2024-02-06
Accepted
2024-02-06 06:11:20
Documents
17
Period of Report
2024-02-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea192779-8k425_phoenix.htm   iXBRL 8-K 81080
2 AMENDMENT NO. 1 TO BUSINESS COMBINATION AGREEMENT, DATED AS OF FEBRUARY 5, 2024, ea192779ex2-1_phoenix.htm EX-2.1 20509
3 SECURITIES PURCHASE AGREEMENT, DATED AS OF FEBRUARY 5, 2024, BY AND AMONG CERO T ea192779ex10-1_phoenix.htm EX-10.1 1632606
  Complete submission text file 0001213900-24-010227.txt   2344858

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pbax-20240205.xsd EX-101.SCH 4205
5 XBRL DEFINITION FILE pbax-20240205_def.xml EX-101.DEF 27296
6 XBRL LABEL FILE pbax-20240205_lab.xml EX-101.LAB 37791
7 XBRL PRESENTATION FILE pbax-20240205_pre.xml EX-101.PRE 25916
18 EXTRACTED XBRL INSTANCE DOCUMENT ea192779-8k425_phoenix_htm.xml XML 7302
Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40877 | Film No.: 24598006
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)